Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Johnson & Johnson (JNJ) vs Las Vegas Sands Corp. (LVS) Price & Performance

Johnson & JohnsonTrade
Las Vegas Sands Corp.Trade

Price performance (Past 24H)

Key statistics

Johnson & Johnson vs Las Vegas Sands Corp. — how do they compare? Johnson & Johnson trades at $250.66 (market cap $598.96B), while Las Vegas Sands Corp. trades at $45.5 (market cap $30.36B). The key difference: Johnson & Johnson is far larger — about 19.7× Las Vegas Sands Corp.'s market cap, and Las Vegas Sands Corp. pays the higher dividend (2.4%). Which is the better fit depends on your goals.

JNJLVS
Market Cap
$598.96B$30.36B
Volume
6,156,228
Sector
HealthConsumer Cyclical
52-Week High
$267.24$69.49
52-Week Low
$164.36$44.78
Enterprise Value
$631.90B$42.75B
Dividend Yield
2.15%2.4%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Johnson & Johnson

Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.

Read more on JNJ

About Las Vegas Sands Corp.

Las Vegas Sands is the world's largest operator of fully integrated resorts, featuring casino, hotel, entertainment, food and beverage, retail, and convention center operations. The company owns the Venetian Macao, Sands Macao, Londoner, Four Seasons Hotel Macao, and Parisian in Macao, and the Marina Bay Sands resort in Singapore. Its Venetian and Palazzo Las Vegas in the U.S. asets were sold to Apollo and VICI for $6.25 billion in 2022. We expect Sands to open a fourth tower in Singapore in 2026. After the sale of its Vegas assets, the company will generate all its EBITDA from Asia, with its casino operations generating the majority of sales.

Read more on LVS